Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.050
-0.150 (-4.69%)
At close: Jun 30, 2026, 4:00 PM EDT
3.004
-0.046 (-1.50%)
After-hours: Jun 30, 2026, 7:49 PM EDT
Larimar Therapeutics Employees
Larimar Therapeutics had 71 employees as of December 31, 2025. The number of employees increased by 6 or 9.23% compared to the previous year.
Employees
71
Change (1Y)
6
Growth (1Y)
9.23%
Revenue / Employee
n/a
Profits / Employee
-$2,338,099
Market Cap
318.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 71 | 6 | 9.23% |
| Dec 31, 2024 | 65 | 23 | 54.76% |
| Dec 31, 2023 | 42 | 16 | 61.54% |
| Dec 31, 2022 | 26 | -5 | -16.13% |
| Dec 31, 2021 | 31 | 3 | 10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Zentalis Pharmaceuticals | 106 |
| Verastem | 102 |
| Lineage Cell Therapeutics | 77 |
| InflaRx | 65 |
| Immuneering | 55 |
| Inhibikase Therapeutics | 35 |
| Opus Genetics | 28 |
LRMR News
- 19 hours ago - Larimar Therapeutics price target lowered to $5 from $7 at Baird - TheFly
- 20 hours ago - Larimar Therapeutics selloff a buying opportunity, says Citi - TheFly
- 1 day ago - Larimar stumbles on safety news even as BLA submission kicks off - TheFly
- 1 day ago - Larimar Therapeutics Transcript: Study update - Transcripts
- 1 day ago - Larimar Therapeutics Press release: Study update - Filings
- 1 day ago - Larimar Therapeutics Slides: Study update - Filings
- 1 day ago - Larimar Therapeutics submits first module of rolling BLA for nomlabofusp - TheFly
- 1 day ago - Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich's Ataxia - GlobeNewsWire